Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immucell (ICCC) Change in Inventory (2016 - 2025)

Immucell (ICCC) has disclosed Change in Inventory for 16 consecutive years, with $1.5 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Change in Inventory rose 837.28% year-over-year to $1.5 million, compared with a TTM value of $2.3 million through Sep 2025, up 3030.88%, and an annual FY2024 reading of -$699218.0, down 139.43% over the prior year.
  • Change in Inventory was $1.5 million for Q3 2025 at Immucell, up from $937060.0 in the prior quarter.
  • Across five years, Change in Inventory topped out at $1.5 million in Q3 2025 and bottomed at -$662278.0 in Q1 2024.
  • Average Change in Inventory over 5 years is $405762.7, with a median of $298412.0 recorded in 2021.
  • The sharpest move saw Change in Inventory surged 24826.58% in 2021, then plummeted 328.54% in 2024.
  • Year by year, Change in Inventory stood at $423004.0 in 2021, then soared by 70.39% to $720756.0 in 2022, then tumbled by 40.87% to $426178.0 in 2023, then plummeted by 181.62% to -$347829.0 in 2024, then skyrocketed by 533.43% to $1.5 million in 2025.
  • Business Quant data shows Change in Inventory for ICCC at $1.5 million in Q3 2025, $937060.0 in Q2 2025, and $244743.0 in Q1 2025.